What medication was given to Donald Trump upon his hospital admission for COVID-19?

Upon Donald Trump’s hospital admission for COVID-19, he was administered Dexamethasone as part of his treatment regimen. Dexamethasone is a corticosteroid that has been shown to reduce mortality in patients with severe COVID-19 who require supplemental oxygen or mechanical ventilation. This medication works by suppressing the immune system's response, which can help reduce inflammation and tissue damage caused by an overactive immune response to the virus.

The use of Dexamethasone became widely recognized following clinical trials that demonstrated its effectiveness in decreasing the risk of death among critically ill patients. It represents a pivotal shift in the treatment of COVID-19, particularly for patients experiencing severe respiratory complications.

Other medications mentioned, such as Hydroxychloroquine and Azithromycin, were widely discussed in the early stages of the pandemic; however, subsequent studies found them to be ineffective for COVID-19 treatment. Remdesivir, while also used in treating COVID-19, is generally indicated for hospitalized patients and acts as an antiviral but focuses more on viral replication rather than inflammation.